What's Going On With Body Contouring Company AirSculpt Technologies Stock Today?

Comments
Loading...
Zinger Key Points

AirSculpt Technologies, Inc. AIRS shares are trading higher on Friday.

Today, the company reported adjusted loss per share of 8 cents, wider than the street view of 4 cents loss. Quarterly sales of $39.178 million (down 17.7% year over year) missed the analyst consensus estimate of $43.386 million.

In the fourth quarter, case volume dropped 16.7% to 3,064.

“While we anticipate facing a tough year-over-year comparison in the first quarter in terms of same center revenue, I am confident we are developing the right operating plan and implementing the right actions to improve our platform and progress toward positive revenue and profit growth,” stated Yogi Jashnani, Chief Executive Officer.

Net loss increased to $5.0 million from $4.6 million in the fiscal year 2023 fourth quarter.

Also Read: Li Auto Tops 500K Deliveries In 2024, Sees Q1 Slowdown

Quarterly adjusted EBITDA dropped to $1.9 million from $10.1 million a year ago. Adjusted EBITDA margin contracted massively to 4.7% from 21.2% in the year-ago period.

As of December 31, 2024, the company had $8.2 million in cash and equivalents, with no availability on its revolving credit facility.

The company generated $11.4 million in operating cash flow for the twelve months ended December.

“We expect the reduction in our marketing activity at the end of 2024 to pressure our first quarter performance,” the CEO added. 

Price Action: AIRS shares are trading higher by 1.87% to $2.995 at last check Friday.

Also Read:

Image via Shutterstock.

AIRS Logo
AIRSAirSculpt Technologies Inc
$1.77-2.47%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
5.12
Growth
13.22
Quality
-
Value
30.20
Price Trend
Short
Medium
Long
Got Questions? Ask
Which healthcare stocks may gain from AirSculpt's struggles?
How could cosmetic procedure companies adapt to changing market conditions?
Will investors find value in AirSculpt's operational plan?
Which competitors might benefit from AirSculpt's declining sales?
How could marketing strategies impact the industry in 2024?
What investment opportunities arise from AirSculpt's cash flow situation?
Are there private equity firms interested in struggling cosmetic companies?
Which emerging technologies could disrupt the body contouring market?
How will consumer confidence affect cosmetic procedures in 2024?
Can AirSculpt's recovery plan attract new investors?

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: